| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443861 | European Journal of Cancer | 2014 | 8 Pages |
Abstract
GDF15, TMEFF2 and VIM promoter methylation allows for accurate identification of UTUC, in tissue and urine and VIM methylation provides relevant prognostic information, especially in high-stage disease. This assay may improve the clinical management of UTUC patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sara Monteiro-Reis, LuÃs Leça, Mafalda Almeida, LuÃs Antunes, Paula Monteiro, Paula C. Dias, António Morais, Jorge Oliveira, Rui Henrique, Carmen Jerónimo,